We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Adult Asthma Genes Are Subset of Childhood-Onset Disease

By LabMedica International staff writers
Posted on 06 May 2019
A large asthma-related genome-wide association study found that the genes involved in adult-onset asthma were largely a subset of genes associated with the childhood-onset disease.

Asthma is a chronic lung disease that inflames and narrows the airways. More...
Asthma causes recurring periods of wheezing, chest tightness, shortness of breath, and coughing. The coughing often occurs at night or early in the morning. Asthma affects people of all ages, but it most often starts during childhood. Childhood-onset and adult-onset asthma differ with respect to severity and associated syndromes. Whether they also differ with respect to genetic risk factors has not been previously investigated in large samples.

Therefore, the goals of a study conducted by investigators at the University of Chicago Medical Center (IL, USA) were to identify shared and distinct genetic risk loci for childhood-onset and adult-onset asthma, and to identify the genes that might mediate the effects of associated variation.

To this end, the investigators carried out genome-wide and transcriptome-wide studies, based on data from the UK Biobank, in individuals with asthma, including adults with childhood-onset asthma (onset before 12 years of age), adults with adult-onset asthma (onset between 26 and 65 years of age), and adults without asthma (controls; aged older than 38 years). In addition, they performed genome-wide association studies (GWAS) for childhood-onset asthma and adult-onset asthma each compared with shared controls.

Enrichment studies determined the tissues in which genes at GWAS loci were most highly expressed, and PrediXcan, a transcriptome-wide gene-based test, was used to identify candidate risk genes. PrediXcan directly tests the molecular mechanisms through which genetic variation affects phenotype. The approach estimates the component of gene expression determined by an individual's genetic profile and correlates "imputed" gene expression with the phenotype under investigation to identify genes involved in the etiology of the phenotype.

The investigators reported that of 376,358 British white individuals from the UK Biobank, they included 37,846 with self-reports of doctor-diagnosed asthma: 9,433 adults with childhood-onset asthma; 21,564 adults with adult-onset asthma; and an additional 6,849 young adults with asthma with onset between 12 and 25 years of age. For the first and second GWAS analyses, 318,237 individuals older than 38 years without asthma were used as controls.

Results revealed 61 independent asthma loci: 23 were childhood-onset specific, one was adult-onset specific, and 37 were shared. Of these loci, 19 were associated with age of asthma onset. PrediXcan identified 113 unique candidate genes at 22 of the 61 GWAS loci.

The results indicated that genetic risk factors for adult-onset asthma were largely a subset of the genetic risk for childhood-onset asthma but with overall smaller effects, suggesting a greater role for non-genetic risk factors in adult-onset asthma. Establishment of the disease in children was driven more by dysregulated allergy and epithelial barrier function genes, whereas the cause of adult-onset asthma was more lung-centered and environmentally determined, but with immune-mediated mechanisms driving disease progression in both children and adults.

"This was the largest asthma-related GWAS yet attempted," said contributing author Dr. Carole Ober, professor of human genetics at the University of Chicago. "We found that the genes involved in adult-onset asthma are largely a subset of genes associated with childhood asthma. At later ages, however, the same genes tend to have smaller effects."

The large asthma study was published in the April 26, 2019, online edition of the journal Lancet Respiratory Medicine.

Related Links:
University of Chicago Medical Center


Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
Collection and Transport System
PurSafe Plus®
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
Rapid Molecular Testing Device
FlashDetect Flash10
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Immunology

view channel
Image: The CloneSeq-SV approach can allow researchers to study how cells within high-grade serous ovarian cancer change over time (Photo courtesy of MSK)

Blood Test Tracks Treatment Resistance in High-Grade Serous Ovarian Cancer

High-grade serous ovarian cancer (HGSOC) is often diagnosed at an advanced stage because it spreads microscopically throughout the abdomen, and although initial surgery and chemotherapy can work, most... Read more

Industry

view channel
Image: The collaboration aims to improve access to Hb variant testing with the Gazelle POC diagnostic platform (Photo courtesy of Hemex Health)

Terumo BCT and Hemex Health Collaborate to Improve Access to Testing for Hemoglobin Disorders

Millions of people worldwide living with sickle cell disease and other hemoglobin disorders experience delayed diagnosis and limited access to effective care, particularly in regions where testing is scarce.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.